Edition:
United Kingdom

UnitedHealth Group Inc (UNH.N)

UNH.N on New York Stock Exchange

247.09USD
22 Mar 2019
Change (% chg)

$-4.93 (-1.96%)
Prev Close
$252.02
Open
$250.57
Day's High
$251.10
Day's Low
$246.99
Volume
1,028,177
Avg. Vol
1,209,722
52-wk High
$287.88
52-wk Low
$212.50

Chart for

About

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHeal... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $191,496.30
Shares Outstanding(Mil.): 966.86
Dividend: 0.75
Yield (%): 1.51

Financials

  UNH.N Industry Sector
P/E (TTM): 23.81 22.22 32.54
EPS (TTM): 8.32 -- --
ROI: -- -0.02 13.82
ROE: 20.39 17.35 15.24

House panel probes Anthem, UnitedHealth over short-term health plans

The U.S. House Committee on Energy and Commerce on Wednesday launched an investigation into 12 health insurers, including Anthem Inc and UnitedHealth Group, over their sale of short-term plans.

13 Mar 2019

House panel probes Anthem, UnitedHealth over short-term health plans

March 13 The U.S. House Committee on Energy and Commerce on Wednesday launched an investigation https://energycommerce.house.gov/newsroom/press-releases/ec-launches-investigation-into-companies-that-sell-or-broker-junk-health into 12 health insurers, including Anthem Inc and UnitedHealth Group, over their sale of short-term plans.

13 Mar 2019

UnitedHealth expands discount program to new employer-sponsored plans

UnitedHealth Group Inc said on Tuesday that starting next year it will expand its drug discount program to all new employer-sponsored health plans and pass on rebates to consumers.

12 Mar 2019

UPDATE 2-UnitedHealth expands discount program to new employer-sponsored plans

March 12 UnitedHealth Group Inc said on Tuesday that starting next year it will expand its drug discount program to all new employer-sponsored health plans and pass on rebates to consumers.

12 Mar 2019

UnitedHealth expands point-of-sale discount program to more clients

March 12 UnitedHealth Group Inc said on Tuesday it would expand from January 2020 its point-of-sale discount program to all new employer-sponsored plans in an effort to make drugs more affordable for patients. The insurer also said that existing members would have the choice of adopting this plan during contract renewal.

12 Mar 2019

Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

NEW YORK A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters.

02 Feb 2019

Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

NEW YORK A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters.

01 Feb 2019

EXCLUSIVE-Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

NEW YORK, Feb 1 A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters.

01 Feb 2019

EXCLUSIVE-Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

NEW YORK, Feb 1 A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters.

01 Feb 2019

REFILE-EXCLUSIVE-Optum to cover Amgen, Eli Lilly migraine drugs, exclude Teva

NEW YORK, Feb 1 Optum, a top U.S. pharmacy benefit manager owned by UnitedHealth Group Inc, has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an Optum client note viewed by Reuters.

01 Feb 2019

Earnings vs. Estimates